xmlns:atom="http://www.w3.org/2005/Atom"
Article 3(3)(a)
CIRCUMSTANCES EXCLUDING MEDICINAL PRODUCTS FROM THE CLASS OF PRESCRIPTION ONLY MEDICINES | |||
---|---|---|---|
Column 1 | Column 2 | Column 3 | Column 4 |
Substance | Maximum strength | Use, pharmaceutical form or route of administration | Maximum dose and maximum daily dose |
Amsacrine | |||
Betamethasone Dipropionate | |||
Bromperidol | |||
Ceftazidime | |||
Ceftizoxime Sodium | |||
Dipivefrin Hydrochloride | |||
Enalapril Maleate | |||
Epirubicin | |||
Fluvoxamine Maleate | |||
Gemfibrozil | |||
Iohexol | |||
Lachesine Chloride | |||
Lithium Citrate | |||
Lofepramine Hydrochloride | |||
Meglumine Ioxaglate | |||
Metronidazole Benzoate | |||
Minoxidil | |||
Mitozantrone Hydrochloride | |||
Nicergoline | |||
Plicamycin | |||
Saralasin Acetate | |||
Sulconazole Nitrate | External (except vaginal use) | ||
Suprofen | |||
Tetroxoprim | |||
Tioconazole | 2.0 per cent | External (except vaginal use) | |
Tobramycin | |||
Vecuronium Bromide |
Note: all columns appearing in Part I of Schedule 1 to the principal Order are set out in this Schedule, although no entries are inserted by this Schedule in column 4 of Part I of Schedule 1 to that Order.